MolNFT v1 · #52311 · protein
EPHB4 kinase domain inhibitor complex
2VWZ · Ephrin type-B receptor 4: “EPHB4 kinase domain inhibitor complex”. X-ray diffraction, 2 ligands (7X6, MG), 1 pocket (best druggability 0.67). MolNFT v1 #52311 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2VWZ
- Type
- protein
- Length
- 274 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Ephrin type-B receptor 4
- EC
- 2.7.10.1
- UniProt
- P54760
- Ligands
- 7X6, MG
- Pockets
- 1 · best druggability 0.67
Structure
x-ray diffraction · 1 distinct chain · 41% helix, 18% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Ephrin type-B receptor 4 (EC 2.7.10.1) | protein | 274 | 41% helix, 18% strand | P54760 |
Ligands and binding sites
- 7X6 · N-[3-[[4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl]amino]phenyl]methanesulfonamide · ligand · chains A
- MG · Magnesium ion · metal · 3 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 407 | 0.67 | 0.80 | 46 | 7X6, MG |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P54760
- Elsewhere: RCSB PDB 2VWZ · PDBe 2VWZ · UniProt P54760
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.